Dostarlimab

From WikiMD.org
Jump to navigation Jump to search
Dostarlimab
TermDostarlimab
Short definitiondostarlimab - (pronounced) (dos-TAR-lih-mab) drug used to treat adults with endometrial cancer or other solid tumors that have come back or progressed and have certain mutations (changes) in genes involved in DNA repair. It is used in patients whose cancer has gotten worse during or after other treatments. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


dostarlimab - (pronounced) (dos-TAR-lih-mab) drug used to treat adults with endometrial cancer or other solid tumors that have come back or progressed and have certain mutations (changes) in genes involved in DNA repair. It is used in patients whose cancer has gotten worse during or after other treatments. It is also being studied in the treatment of other types of cancer. Dostarlimab attaches to a protein called PD-1 found on T cells. Dostarlimab can block PD-1 and help the immune system kill cancer cells. It's a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called Jemperli

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski